Biliuria
ICD-10 R82.2 is a billable code used to indicate a diagnosis of biliuria.
Biliuria refers to the presence of bilirubin in the urine, which is an abnormal finding that can indicate various underlying conditions. Bilirubin is a yellow compound that is produced during the normal breakdown of red blood cells. Under normal circumstances, bilirubin is processed by the liver and excreted in bile. However, when there is an excess of bilirubin in the bloodstream, it can spill over into the urine, leading to biliuria. This condition is often associated with liver dysfunction, hemolytic anemia, or biliary obstruction. Clinically, patients may present with dark urine, which can be a key indicator of biliuria. Laboratory findings typically include elevated urine bilirubin levels, which can be detected through urinalysis. It is essential to differentiate biliuria from other causes of dark urine, such as hematuria or myoglobinuria, to ensure accurate diagnosis and treatment.
Detailed history and physical examination findings, including any associated symptoms such as jaundice or abdominal pain.
Patients presenting with jaundice, dark urine, and elevated liver enzymes.
Consideration of liver function tests and imaging studies to determine the underlying cause.
Acute care documentation including vital signs, presenting symptoms, and immediate lab results.
Patients with acute abdominal pain and dark urine requiring rapid assessment.
Timely documentation of findings to facilitate urgent care decisions.
Used when urinalysis is performed to confirm biliuria.
Document the reason for urinalysis and any relevant clinical findings.
Ensure that the urinalysis is linked to the clinical suspicion of biliuria.
The primary cause of biliuria is often liver dysfunction, hemolytic anemia, or biliary obstruction, leading to excess bilirubin in the urine.
